3 employees
Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.
2021
$16M
from 2 investors over 2 rounds
Surf Bio raised $16M on April 12, 2022
Investors: Breakout Ventures and Perceptive Advisors